FDA approves patisiran to treat hereditary transthyretin amyloidosis
- PMID: 30158559
- DOI: 10.1038/s41582-018-0065-0
FDA approves patisiran to treat hereditary transthyretin amyloidosis
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials